Author Archives: Brit Thompson

Meet a CanCan Instructor: Lauren Grabowski

The Rivkin Center’s CanCan Program The Rivkin Center for Ovarian Cancer’s CanCan program provides free health education workshops. CanCan instructors educate women about their breast and ovarian health and cancer risks. Say hello to Lauren Grabowski, CanCan instructor.   About Lauren Where are you from? Vacaville, California (Cowtown!) Where do you live now and what […]

Meet a CanCan Facilitator: Ilyse Wagner

ilyse-blog-header

The Rivkin Center’s CanCan Program The Rivkin Center for Ovarian Cancer’s CanCan program provides free health education workshops across the west coast. CanCan facilitators share their cancer journey with CanCan party attendees and help educate women on ovarian and breast health. Say hello to Ilyse Wagner, CanCan facilitator.   About Ilyse Where are you from? […]

2018 SummeRun Honoree: Debbie McKenzie

summerun-honoree-header

We are thrilled to have Debbie McKenzie as our 2018 SummeRun honoree! Debbie and her family and friends have been supporters of the SummeRun for the past three years and are great friends of the Rivkin Center. We know Debbie’s story will inspire you as you participate in this year’s event! Debbie’s Story Debbie had […]

Introducing Dr. Mary-Claire King: Symposium Keynote

rivkin-symposium-keynote-speaker

We’re excited to share that Dr. Mary-Claire King will be our keynote speaker at the Rivkin Center’s 12th Biennial Ovarian Cancer Research Symposium. Dr. King first discovered BRCA1, the breast and ovarian cancer gene, in 1990. Her work on BRCA1 was a game-changer for how scientists thought about the role of genetics in complex diseases […]

How to Reduce Your Risk for Breast and Ovarian Cancer

reduce-ovarian-cancer-risk

In addition to genetics and family history, environment plays a role in breast and ovarian cancer risk. Here are 5 lifestyle behaviors that have been scientifically shown to reduce your risk of ovarian and breast cancer: Be Physically Active — at least 30 minutes per day, 5 days per week Exercise has numerous health benefits, […]

Community Fundraising: Mother’s Day Dash in Shelton, WA

The Mother’s Day Dash on Sunday, May 13th in Shelton, WA hosted by the Conklin family raised nearly $5,000 in the fight against ovarian cancer. The Dash is a 4 mile run/walk community fundraising event for the Swedish SummeRun & Walk to benefit the Rivkin Center. The Conklin’s are longtime supporters of the SummeRun and […]

Meet a CanCan Ambassador: Izzy Shahmirza

ucla-cancan-ambassador

Meet an Ambassador The Rivkin Center for Ovarian Cancer’s CanCan program provides free health education workshops across the west coast. CanCan campus ambassadors are the feet-on-the-ground representatives at colleges for the Rivkin Center, helping set up workshops, identify opportunities to reach more students, and so much more. Say hello to Izzy Shahmirza, CanCan ambassador at […]

Top 7 Myths About Ovarian and Breast Cancer

breast-and-ovarian-cancer-myths

Our CanCan parties are a fun, frank way to educate women on ovarian and breast cancer risks and symptoms. They also serve as an opportunity to bust those pesky cancer myths that continue to circulate (but have little or no scientific backing). Curious what questions we get asked the most at CanCan parties? Top Seven Ovarian and […]

Meet a CanCan Facilitator: Stacy Goldsby

STACY-GOLDSBY

The Rivkin Center’s CanCan Program The Rivkin Center for Ovarian Cancer’s CanCan program provides free health education workshops. CanCan facilitators are cancer survivors who share their in an effort to educate women about their breast and ovarian health and cancer risks. Say hello to Stacy Goldsby, CanCan facilitator. About Stacy Where are you from? Oakland, Ca […]

Promising news for ovarian cancer treatment with another FDA approval for PARP inhibitors

ovarian-cancer-in-the-news

PARP inhibitors represent an important new class of anticancer agents that are having a major impact on ovarian cancer treatment. These drugs target vulnerabilities in DNA damage response and repair pathways especially in cancer cells that have defects in BRCA and related genes. In an important clinical development announced April 6, 2018, the FDA expanded […]

X